Narrow-moat Quest Diagnostics delivered second-quarter results that slightly exceeded our expectations on the top line, but that was offset by earnings that fell slightly short of our full-year ...
LOS ANGELES, Nov 17 (Reuters) - Quest Diagnostics Inc's molecular test for identifying patients infected with the H1N1 flu virus has been approved by European regulators and is available for ...
LOS ANGELES (Reuters) - Quest Diagnostics Inc's molecular test for identifying patients infected with the H1N1 flu virus has been approved by European regulators and is available for distribution to ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈